Human Growth Hormone

Human Growth Hormone (somatotropin), a recombinant 191-amino-acid polypeptide mimicking the endogenous pituitary hormone, is used as replacement therapy for growth failure in children and conditions like muscle wasting in adults by stimulating linear growth, metabolism, and insulin-like growth factor-1 production.

Brief glance

The primary outcome is Anti-Aging, but it's also used for Performance, Recovery & Repair, Metabolic. This compound is considered a Hormone. It may be compounded in 503A pharmacies where allowed. It is not listed under a DEA schedule.

Overview

Human Growth Hormone (HGH), also known as somatotropin, is a recombinant peptide hormone that replaces deficient endogenous production from the pituitary gland. It is FDA-approved for treating growth failure in children due to growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, chronic kidney disease, and idiopathic short stature, as well as adult growth hormone deficiency, HIV-associated wasting, and short bowel syndrome. Administered via subcutaneous injection, HGH promotes linear growth, increases lean body mass, and modulates metabolic functions including protein synthesis and fat utilization.

Human Growth Hormone (HGH), also known as somatotropin, is a peptide hormone produced by the anterior pituitary gland that stimulates growth in children and regulates metabolism in both children and adults. As a pharmaceutical active ingredient, synthetic HGH is FDA-approved for treating growth hormone deficiency and conditions causing short stature in children, such as Turner syndrome, Prader-Willi syndrome, and chronic kidney disease. It promotes linear growth by acting on chondrocytes and osteoblasts in cartilage and bone, while also increasing insulin-like growth factor-1 (IGF-1) production to influence glucose metabolism and tissue maintenance. In adults, it is prescribed for growth hormone deficiency and certain muscle-wasting conditions associated with HIV/AIDS. Administered via subcutaneous injection, HGH requires careful medical supervision due to its potent effects on body composition and metabolic pathways.

Benefits

Human Growth Hormone (somatropin) is FDA-approved for treating growth hormone deficiency (GHD) in children to stimulate normal growth and development, and in adults to replace deficient hormone levels, improving lean body mass, reducing fat mass, and enhancing bone mineral density.¹,²,³,⁴ In children, it addresses short stature associated with conditions such as Turner syndrome, Prader-Willi syndrome, chronic kidney disease, and being born small for gestational age.²,⁴ Additional approved adult indications include short bowel syndrome and HIV-associated muscle wasting, with evidence showing benefits in exercise capacity, quality of life, serum lipids, and cardiovascular risk markers like reduced C-reactive protein in GHD patients.²,³,⁴

Side effects

Common side effects of synthetic human growth hormone include carpal tunnel syndrome, joint and muscle pain, swelling or edema in the arms and legs, increased insulin resistance or high blood sugar potentially leading to type 2 diabetes, gynecomastia in males, and high cholesterol levels.²,⁴,⁵ Additional risks involve numbness and tingling of the skin, headaches, high blood pressure, and potential contributions to tumor growth or higher cancer risk, particularly in those with prior malignancies or cranial radiation history.²,⁵,⁶ Safety considerations include contraindications in patients with active cancer, Prader-Willi syndrome patients who are severely obese or have breathing issues, allergies to somatropin or components like m-cresol, and those with intracranial hypertension; regular monitoring of thyroid function, blood glucose, blood pressure, and for signs of scoliosis worsening, pancreatitis, or limping in rapidly growing children is essential.⁶,⁷ Long-term excess can lead to acromegaly with irreversible bone thickening, cardiovascular complications, and increased mortality risk as observed in historical cohorts.⁸,⁹,¹⁰ Dosing must be carefully titrated under medical supervision to minimize dose-dependent effects like fluid retention and injection site reactions.⁶,¹¹

Mechanisms of action

Human Growth Hormone (HGH), also known as somatotropin, exerts its effects through both direct and indirect mechanisms at the molecular level.¹²,¹³ Directly, HGH binds to the growth hormone receptor (GHR), a dimeric cytokine receptor on target cells such as those in liver, cartilage, and bone, inducing receptor dimerization and activation of Janus kinase 2 (JAK2).¹²,¹³,¹⁴ This triggers tyrosine phosphorylation of JAK2 and the receptor, leading to phosphorylation and nuclear translocation of signal transducer and activator of transcription (STAT) proteins, primarily STAT5, which induce transcription of genes promoting cell proliferation, protein synthesis, and metabolism.¹²,¹³,¹⁴ Indirectly, HGH stimulates hepatocytes to produce insulin-like growth factor-1 (IGF-1), which circulates to bind IGF-1 receptors on peripheral tissues, activating tyrosine kinase pathways that enhance anabolism, inhibit apoptosis, and drive tissue growth including chondrocyte proliferation and linear bone growth.¹²,¹³,¹⁵ Additionally, HGH promotes lipolysis in adipose tissue via hormone-sensitive lipase and can antagonize insulin action, contributing to its metabolic effects.¹³